Search research articles
Contact Us
Filters
Showing results (71-80 of 141) with videos related to
Page
of 15
Sort By:
Frontiers in Immunology
|
June 26, 2023
Liposomes loaded with vitamin D3 induce regulatory circuits in human dendritic cells
Noémi Anna Nagy, Fernando Lozano Vigario, Rinske Sparrius, et al.
Lupus Science & Medicine
|
September 6, 2024
Learning from serum markers reflecting endothelial activation: longitudinal data in childhood-onset systemic lupus erythematosus
Sandy C Bergkamp, Nick D Bergkamp, Mohamed Javad Wahadat, et al.
European Journal of Immunology
|
March 2, 2024
Retinoic acid-loaded liposomes induce human mucosal CD103<sup>+</sup> dendritic cells that inhibit Th17 cells and drive regulatory T-cell development in vitro
Noémi Anna Nagy, Florianne M J Hafkamp, Rinske Sparrius, et al.
Atherosclerosis
|
February 7, 2018
Noncanonical NF-κB signaling in microvessels of atherosclerotic lesions is associated with inflammation, atheromatous plaque morphology and myocardial infarction
Chrissta X Maracle, Rabia Agca, Boy Helder, et al.
RMD Open
|
April 20, 2024
Patient-perspective and feasibility of home finger-prick testing to complement and facilitate large-scale research in rheumatology
Yaëlle R Besten, Laura Boekel, Maurice Steenhuis, et al.
Expert Opinion on Drug Safety
|
July 31, 2020
Stakeholders' perspectives on a patient-reported outcome measure-based drug safety monitoring system for immune-mediated inflammatory diseases
Leanne J Kosse, Naomi T Jessurun, Harald E Vonkeman, et al.
BMJ Open
|
February 6, 2025
Multicentre, 26-week, open-label phase 2 trial of the JAK inhibitor filgotinib in Behçet's disease, idiopathic inflammatory myopathies and IgG4-related disease: DRIMID study protocol
Bettina C Geertsema-Hoeve, Jan A M van Laar, Joost Raaphorst, et al.
Frontiers in Immunology
|
June 30, 2022
Differential Contribution of NF-κB Signaling Pathways to CD4<sup>+</sup> Memory T Cell Induced Activation of Endothelial Cells
Kim C M Jeucken, Charlotte C N van Rooijen, Yik Y Kan, et al.
Expert Opinion on Drug Safety
|
June 12, 2020
Immune-mediated inflammatory disease patients' preferences in adverse drug reaction information regarding biologics
Leanne J Kosse, Gerda Weits, Harald E Vonkeman, et al.
Annals of the Rheumatic Diseases
|
July 19, 2025
Development of bispecific antibodies that drive selective targeted local complement inhibition on rheumatoid arthritis-related antigens
Haiyu Wang, Saskia Nugteren, Rick J Groenland, et al.
Page
of 15
Search research articles
Search
Showing results (71-80 of 141) with videos related to
Sort By:
Page
of 15
Frontiers in Immunology
|
June 26, 2023
Liposomes loaded with vitamin D3 induce regulatory circuits in human dendritic cells
Noémi Anna Nagy, Fernando Lozano Vigario, Rinske Sparrius, et al.
Lupus Science & Medicine
|
September 6, 2024
Learning from serum markers reflecting endothelial activation: longitudinal data in childhood-onset systemic lupus erythematosus
Sandy C Bergkamp, Nick D Bergkamp, Mohamed Javad Wahadat, et al.
European Journal of Immunology
|
March 2, 2024
Retinoic acid-loaded liposomes induce human mucosal CD103<sup>+</sup> dendritic cells that inhibit Th17 cells and drive regulatory T-cell development in vitro
Noémi Anna Nagy, Florianne M J Hafkamp, Rinske Sparrius, et al.
Atherosclerosis
|
February 7, 2018
Noncanonical NF-κB signaling in microvessels of atherosclerotic lesions is associated with inflammation, atheromatous plaque morphology and myocardial infarction
Chrissta X Maracle, Rabia Agca, Boy Helder, et al.
RMD Open
|
April 20, 2024
Patient-perspective and feasibility of home finger-prick testing to complement and facilitate large-scale research in rheumatology
Yaëlle R Besten, Laura Boekel, Maurice Steenhuis, et al.
Expert Opinion on Drug Safety
|
July 31, 2020
Stakeholders' perspectives on a patient-reported outcome measure-based drug safety monitoring system for immune-mediated inflammatory diseases
Leanne J Kosse, Naomi T Jessurun, Harald E Vonkeman, et al.
BMJ Open
|
February 6, 2025
Multicentre, 26-week, open-label phase 2 trial of the JAK inhibitor filgotinib in Behçet's disease, idiopathic inflammatory myopathies and IgG4-related disease: DRIMID study protocol
Bettina C Geertsema-Hoeve, Jan A M van Laar, Joost Raaphorst, et al.
Frontiers in Immunology
|
June 30, 2022
Differential Contribution of NF-κB Signaling Pathways to CD4<sup>+</sup> Memory T Cell Induced Activation of Endothelial Cells
Kim C M Jeucken, Charlotte C N van Rooijen, Yik Y Kan, et al.
Expert Opinion on Drug Safety
|
June 12, 2020
Immune-mediated inflammatory disease patients' preferences in adverse drug reaction information regarding biologics
Leanne J Kosse, Gerda Weits, Harald E Vonkeman, et al.
Annals of the Rheumatic Diseases
|
July 19, 2025
Development of bispecific antibodies that drive selective targeted local complement inhibition on rheumatoid arthritis-related antigens
Haiyu Wang, Saskia Nugteren, Rick J Groenland, et al.
Page
of 15